Gabriel Hortobagyi:

Results from the NATALEE trial: impact on current practiceПодробнее

Dr. Gabriel Hortobagyi on the Impact of MONALEESA-2 Trial in HR+ Breast CancerПодробнее

Dr. Hortobagyi on MONALEESA-2 Trial Results in Breast CancerПодробнее

ELO TV Featuring Gabriel N. Hortobagyi, M.D., MACP, FASCOПодробнее

Dr. Gabriel Hortobagyi, MDПодробнее

Congratulations, 2019 Potamkin Prize Winner, Gabriel Hortobagyi, MD, MACP, FASCOПодробнее

ESMO 2016: Press brief on the MONALEESA-2 clinical trial on breast cancerПодробнее

ELO TV Featuring Gabriel N. Hortobagyi, M.D., MACP, FASCO. TrailerПодробнее

Dr. Gabriel Hortobagyi remarks; overview of targeted therapies, hormonal therapyПодробнее

SABCS11 PC_ Gabriel N. Hortobagyi_ Everolimus for Postmenopausal WomenПодробнее

What guidance do you give patients and family coping with advanced breast cancer?Подробнее

Dr. Gabriel Hortobagyi (UT MD Anderson Cancer Center) on impact of BCRF FundingПодробнее

Dr. Gabriel N. Hortobagyi: 2015 Giants of Cancer Care WinnerПодробнее

Gabriel N. Hortobagyi, et al.Подробнее

Dr. Hortobagyi Discusses the BOLERO-2 TrialПодробнее

Gabriel N. Hortobagyi, MD, FACPПодробнее